Infliximab and Ulcerative Colitis

Ulcerative colitis (UC) is one of the main forms of inflammatory bowel disease. The condition causes the colon and rectum to become inflamed and ulcerated.

Bad Experience with Remicade (Infliximab) Infusion

PDF) Pediatric Ulcerative Colitis: The Therapeutic Road to Infliximab

PDF) Safety and effectiveness of infliximab for inflammatory bowel diseases in clinical practice

Ulcerative colitis - The Lancet

Management of moderate to severe ulcerative colitis - American Gastroenterological Association

GEN0422_007b_13789_.jpg

Crohn's & Colitis Foundation on X: The FDA approved Celltrion USA's ZYMFENTRA® (infliximab-dyyb), the first and only subcutaneous infliximab injection, for the treatment of moderate to severe ulcerative colitis and Crohn's disease.

Bad Experience with Remicade (Infliximab) Infusion

JCM, Free Full-Text

Infliximab - Wikipedia

Biologic Therapies for Inflammatory Bowel Disease: Strategies for

Comparative efficacy of antitumor necrosis factor agents and tacrolimus in naïve steroid-refractory ulcerative colitis patients

International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease